SCHEMBL8708987

SCHEMBL8708987

O=C(Oc1ccc([N+](=O)[O-])cc1)c1cccnc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 9/20 1.00
ALDH1A1 P00352 5/20 0.75
KMT2A Q03164 10/20 0.65
ATM Q13315 1/20 0.65
CRHBP P24387 1/20 0.64
HTT P42858 1/20 0.64
CRHR2 Q13324 1/20 0.64
GAA P10253 1/20 0.64
HPGD P15428 1/20 0.64
KDM4E B2RXH2 1/20 0.62
CYP1A2 P05177 2/20 0.61
CYP2C9 P11712 2/20 0.61
LMNA P02545 3/20 0.60
THRB P10828 1/20 0.60
MEN1 O00255 1/20 0.59
CYP3A4 P08684 1/20 0.59
TSHR P16473 1/20 0.58
CYP2C19 P33261 1/20 0.58
PKM P14618 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21243070 0.86 KMT2A (0.84) MAPTALDH1A1KMT2AATMKDM4E
SCHEMBL7362981 0.85 MAPT (0.73) MAPTALDH1A1KMT2AATMCRHBP
SCHEMBL10959920 0.84 MAPT (0.71) MAPTALDH1A1KMT2AGAAHPGD
SCHEMBL17087080 0.83 MAPT (0.70) MAPTALDH1A1KMT2AATMCRHBP
SCHEMBL8605626 0.83 MAPT (0.70) MAPTALDH1A1KMT2AATMCRHBP
SCHEMBL8706583 0.82 HSD17B10 (0.71) MAPTALDH1A1KMT2AGAAHPGD
SCHEMBL527544 0.82 KMT2A (0.71) MAPTALDH1A1KMT2AHTTGAA
SCHEMBL12736161 0.81 MAPT (0.72) MAPTALDH1A1KMT2AHTTLMNA
SCHEMBL13292702 0.80 MAPT (0.67) MAPTALDH1A1KMT2AGAAHPGD
SCHEMBL502583 0.80 ALDH1A1 (0.78) MAPTALDH1A1KMT2AATMKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101124229-A Novel heterocyclic compounds for the treatment of inflammatory and allergic disorders GLENMARK PHARMACEUTICALS SA (CH) 2008-02-13 CN claimed
WO-2024259930-A9 PHOSPHONATE COMPOUND AND MEDICAL USE THEREOF 润佳(苏州)医药科技有限公司 2025-04-24 WO disclosed
WO-2024259930-A1 PHOSPHONATE COMPOUND AND MEDICAL USE THEREOF 润佳(苏州)医药科技有限公司 2024-12-26 WO disclosed
CN-118388480-A 6-Arylquinazolin-4-amine and 6-arylpyridopyrimidine-4-amine derivatives and their use as PI3K delta covalent inhibitors 西安交通大学 2024-07-26 CN disclosed
CN-117285566-A Phosphonate compound and medical application thereof 润佳(苏州)医药科技有限公司 2023-12-26 CN disclosed
US-20220170904-A1 SYSTEMS AND METHODS FOR MONITORING BIOLOGICAL TISSUE DEGRADATION ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2022-06-02 US disclosed
CN-107531701-A Crystalline compounds as semicarbazide-sensitive amine oxidase (SSAO) enzyme inhibitors 普罗克斯马根有限公司 2018-01-02 CN disclosed
CN-107530330-A The treatment of pain 普罗克斯马根有限公司 2018-01-02 CN disclosed
CN-107531702-A Pharmaceutical salt forms of semicarbazide-sensitive amine oxidase (SSAO) inhibitors 普罗克斯马根有限公司 2018-01-02 CN disclosed
CN-104428305-A 1-phenyl-substituted heterocyclyl derivatives and their use as prostaglandin d2 receptor modulators ACTELION PHARMACEUTICALS LTD 2015-03-18 CN disclosed
CN-101124229-B Novel heterocyclic compounds for the treatment of inflammatory and allergic disorders GLENMARK PHARMACEUTICALS SA 2012-07-18 CN disclosed
CN-102232073-A New compounds I BIOVITRUM AB PUBL 2011-11-02 CN disclosed
CN-101124229-A Novel heterocyclic compounds for the treatment of inflammatory and allergic disorders GLENMARK PHARMACEUTICALS SA (CH) 2008-02-13 CN disclosed
US-5763404-A LUTEINIZING HORMONE RELEASING HORMONE UNIV TEXAS (US) 1998-06-09 US disclosed
US-5470947-A Lutenizing hormone-releasing hormone, contraceptives BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 1995-11-28 US disclosed
EP-0377665-B1 EFFECTIVE ANTAGONISTS OF THE LUTEINIZING HORMONE RELEASING HORMONE WHICH RELEASE NEGLIGIBLE HISTAMINE UNIV TEXAS (US) 1995-07-12 EP disclosed
EP-0489581-A2 Cosmetic composition UNILEVER PLC (GB) 1992-06-10 EP disclosed
EP-0377665-A1 EFFECTIVE ANTAGONISTS OF THE LUTEINIZING HORMONE RELEASING HORMONE WHICH RELEASE NEGLIGIBLE HISTAMINE. UNIV TEXAS (US) 1990-07-18 EP disclosed
US-4935491-A CONTRACEPTIVES WITH REDUCED SIDE EFFECTS BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 1990-06-19 US disclosed
WO-1989001944-A1 EFFECTIVE ANTAGONISTS OF THE LUTEINIZING HORMONE RELEASING HORMONE WHICH RELEASE NEGLIGIBLE HISTAMINE BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 1989-03-09 WO disclosed